Parenteral Drug Association
  

Add Lean Manufacturing: What is the State of Lean/Six Sigma in Pharma and Biotech? headlines to your news reader:

Click to view RSS Feed

Or, paste the URL in the box below into your preferred RSS reader.



conferences

Lean Manufacturing: What is the State of Lean/Six Sigma in Pharma and Biotech?

AgendaRegister Now
March 17, 2010 | Gaylord Palms Resort and Convention Center | Orlando, Florida
Add to Calendar

Overview

This post-conference workshop is a part of the 2010 PDA Annual Meeting, March 15-19, 2010. 

Learn how Lean Six Sigma relates to the new paradigm of manufacturing control under development with the advent of the ICH Q8, Q9 and 10 documents. The pharmaceutical industry is under significant cost constraints and must harness the tools of continual improvement while focusing on value added activities. This meeting will bring together content experts and industry practitioners in a workshop environment to discuss the current state of Lean Six Sigma in the industry and the barriers/hurdles to its implementation.

This is a problem-solving workshop and will give you the opportunity to discuss issues with industry experts and peers in an effort to meet operational excellence goals. Rather than a standard workshop with presentations, this interactive workshop includes panel discussions and Q&A. The agenda is set around five topics with participants alternating between table and group discussions. This interactive workshop will capture the experiences of the participants, as well as will share the experiences of leaders and facilitators. The five topics include:

  1. How would you define the state of Lean Six Sigma in the pharma and biopharma industries?
  2. How do you measure value?
  3. How would you evaluate your company's implementation of tools and management systems to analyze risk? What have been the potential pitfalls and unintended consequences?
  4. If we as an industry know we need to improve the efficiency of our systems and operations, why has Six Sigma not become routine business practice in the pharma and biopharma industries? What are practical barriers and enablers?
  5. How do you maintain a state of control of sustainability while always in a state of continual improvement?

Attend this workshop that will bring together both skeptics and advocates for a thought provoking debate.

Learning Objectives

At the completion of this conference, participants will be able to: 

  • Discuss current practices in pharmaceutical and biopharmaceutical manufacturing
  • Understand the barriers to successful implementation
  • How to define "value"
  • How to sustain implementation 

Who Should Attend

This workshop will provide value to varied groups of individuals including:

Operations | Regulatory Affairs | Manufacturing Excellence Professionals | Engineering | Quality Assurance | Logistics and Solution Providers | Management

Contact

For conference inquiries, please contact:

Leon D. Lewis

Assistant Manager, Programs & Web Seminars
Tel: +1 (301) 656-5900 ext. 149
Fax: +1 (301) 986-0296
E-mail: lewis@pda.org

For registration inquiries, please contact:

Patresa Day
Manager, Registration & Customer Accounts Representative
Tel: +1 (301) 656-5900 ext. 115
Fax: +1 (301) 986-0296
E-mail: day@pda.org

 
From: 
Email:  
To: 
Email:  
Subject: 
Message: